Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma characterized by the rapid proliferation of B-lymphoid cells. It primarily affects lymph nodes in multiple sites and is associated with genetic mutations, particularly involving the MYC oncogene. Accurate coding with ICD-10 Code C83.78 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this serious condition.
ICD-10 Code C83.78 represents Burkitt lymphoma affecting lymph nodes at multiple sites. This aggressive lymphoma is characterized by rapid tumor growth and can lead to significant morbidity if not promptly diagnosed and treated. This code should be used in clinical documentation and billing when a patient presents with symptoms indicative of Burkitt lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma that often presents with rapidly enlarging lymph nodes. It is associated with chromosomal translocations involving the MYC gene, leading to uncontrolled cell proliferation. Prompt medical attention is crucial due to its aggressive nature and potential for systemic involvement.
ICD-10 Code C83.78 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to Burkitt lymphoma. This code plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.
In SOAP notes, ICD-10 Code C83.78 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Burkitt lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Burkitt lymphoma requires urgent medical intervention due to its aggressive nature. Treatment typically involves chemotherapy and may necessitate hospitalization for intensive management.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.78 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, for the first hour. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
Common Questions About Using ICD-10 Code C83.78 for Burkitt lymphoma, lymph nodes of multiple sites
What are the common symptoms of Burkitt lymphoma?
Common symptoms include rapidly enlarging lymph nodes, abdominal pain, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and decreased appetite.
How is Burkitt lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of malignant B-cells.
What is the treatment for Burkitt lymphoma?
Treatment usually consists of intensive chemotherapy regimens. In some cases, radiation therapy may also be utilized, depending on the extent of the disease.
Is Burkitt lymphoma contagious?
No, Burkitt lymphoma is not contagious. It is a type of cancer that arises from genetic mutations in B-lymphoid cells and is not transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes